"Polyneuropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.
Descriptor ID |
D011115
|
MeSH Number(s) |
C10.668.829.800
|
Concept/Terms |
Polyneuropathy, Motor- Polyneuropathy, Motor
- Motor Polyneuropathies
- Motor Polyneuropathy
- Polyneuropathies, Motor
Polyneuropathy, Familial- Polyneuropathy, Familial
- Familial Polyneuropathies
- Familial Polyneuropathy
- Polyneuropathies, Familial
- Polyneuropathy, Inherited
- Inherited Polyneuropathies
- Inherited Polyneuropathy
- Polyneuropathies, Inherited
Polyneuropathy, Acquired- Polyneuropathy, Acquired
- Acquired Polyneuropathies
- Acquired Polyneuropathy
- Polyneuropathies, Acquired
Polyneuropathy, Critical Illness- Polyneuropathy, Critical Illness
- Critical Illness Polyneuropathies
- Critical Illness Polyneuropathy
- Polyneuropathies, Critical Illness
|
Below are MeSH descriptors whose meaning is more general than "Polyneuropathies".
Below are MeSH descriptors whose meaning is more specific than "Polyneuropathies".
This graph shows the total number of publications written about "Polyneuropathies" by people in this website by year, and whether "Polyneuropathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 3 | 0 | 3 |
2019 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
2022 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyneuropathies" by people in Profiles.
-
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia. 2023 03; 66(3):579-589.
-
Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study. Int J Obes (Lond). 2022 07; 46(7):1366-1374.
-
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy. BMJ Open. 2022 Feb 03; 12(2):e057142.
-
Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy. Curr Diabetes Rev. 2022; 18(5):e120421192781.
-
Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study. Environ Health Perspect. 2020 12; 128(12):127013.
-
Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy. BMJ Open Diabetes Res Care. 2019; 7(1):e000752.
-
Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia. Exp Neurol. 2019 10; 320:112958.
-
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort. Diabetes Care. 2019 02; 42(2):240-247.
-
A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study. Diabetes. 2018 11; 67(11):2434-2442.
-
Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study. Diabetes Metab Res Rev. 2018 07; 34(5):e3000.